Hematopoietic Stem Cell TransplantationStem Cell TransplantationTransplantation, HomologousTransplantation, AutologousStem CellsPeripheral Blood Stem Cell TransplantationTransplantation ConditioningClone CellsGraft vs Host DiseaseHematologic NeoplasmsBone Marrow TransplantationLiver TransplantationHematopoietic Stem CellsTransplantation ChimeraMesenchymal Stem Cell TransplantationTreatment OutcomeTissue DonorsCord Blood Stem Cell TransplantationGraft SurvivalKidney TransplantationCell TransplantationEmbryonic Stem CellsMyeloablative AgonistsAdult Stem CellsBusulfanHistocompatibility TestingRecurrenceMultiple MyelomaWhole-Body IrradiationCombined Modality TherapyRemission InductionMelphalanRetrospective StudiesImmunosuppressive AgentsHistocompatibilityHematopoietic Stem Cell MobilizationGraft vs Leukemia EffectHeart TransplantationPluripotent Stem CellsCell DifferentiationLeukemiaTransplantation ImmunologyLung TransplantationNeural Stem CellsStem Cell NicheDisease-Free SurvivalTime FactorsVidarabineSurvival RateSurvival AnalysisMesenchymal Stromal CellsAntigens, CD34Graft RejectionCyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsHepatic Veno-Occlusive DiseaseSalvage TherapyLeukemia, Myeloid, AcuteInduced Pluripotent Stem CellsOrgan TransplantationChimerismGraft vs Tumor EffectTransplantation, IsogeneicHLA AntigensSiblingsLymphocyte TransfusionHematologic DiseasesMyelodysplastic SyndromesFollow-Up StudiesTransplantationMultipotent Stem CellsLymphoma, Non-HodgkinIslets of Langerhans TransplantationAntilymphocyte SerumImmunosuppressionGranulocyte Colony-Stimulating FactorPrecursor Cell Lymphoblastic Leukemia-LymphomaBone Marrow CellsCell LineageLeukemia, Myelogenous, Chronic, BCR-ABL PositiveFetal Stem CellsHematopoiesisCytomegalovirus InfectionsLymphocyte DepletionCells, CulturedUnrelated DonorsCytarabineStem Cell FactorHodgkin DiseaseLiving DonorsPrognosisAnemia, AplasticPancreas TransplantationT-LymphocytesAcute DiseaseFlow CytometryEtoposideCyclosporineCell ProliferationLeukapheresis